NYXH

Handel nachbörslich: 7.79 0.09 +1.17%

Nyxoah Sa (NYXH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1166)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NYXH's Discussions on Twitter

Vergleichen Sie NYXH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NYXH Nyxoah Sa	7.70	290.08M	4.71M	-46.77M	-60.34M	-1.6792
ISRG Intuitive Surgical Inc	540.60	189.82B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	177.27	49.98B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	89.30	44.00B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	255.88	37.05B	5.02B	1.31B	1.56B	8.91
WST West Pharmaceutical Services Inc	221.22	16.36B	2.90B	467.20M	306.90M	6.37

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-07-31	Eingeleitet	H.C. Wainwright	Buy
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2022-04-21	Eingeleitet	Oppenheimer	Outperform
2022-04-06	Eingeleitet	Wolfe Research	Peer Perform
2021-12-21	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-07-28	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Vergleichen Sie NYXH mit anderen Aktien

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

(NYXH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025 - Yahoo Finance

Major Governance Shift: Nyxoah Grants Long-term Shareholders New Board Nomination Rights - Stock Titan

Cantor Fitzgerald Forecasts Nyxoah FY2026 Earnings - Defense World

Ameriprise Financial Inc. Takes $135,000 Position in Nyxoah S.A. (NASDAQ:NYXH) - Defense World

When the Price of (NYXH) Talks, People Listen - news.stocktradersdaily.com

Top Premarket Decliners - marketscreener.com

Millennium Management LLC Trims Stock Holdings in Nyxoah S.A. (NASDAQ:NYXH) - Defense World

Nyxoah Announces Change in Shareholder Voting Rights - TipRanks

Vestal Point Capital Cuts Nyxoah Holdings by 40%: Major Ownership Shift Revealed - Stock Titan

Nyxoah to Present at the Jefferies Global Healthcare Conference - The Manila Times

Nyxoah CEO Showcases Revolutionary Sleep Apnea Treatment at Major Jefferies Healthcare Conference - Stock Titan

Nyxoah SA Updates Share Capital and Voting Rights - TipRanks

Information on the total number of voting rights and shares - Yahoo

Head-To-Head Survey: Inspire Medical Systems (NYSE:INSP) versus Nyxoah (NASDAQ:NYXH) - Defense World

Cantor maintains Nyxoah stock Overweight with $14 target By Investing.com - Investing.com Nigeria

Nyxoah Announces CE Mark Approval For Genio® 2.1 - Barchart.com

Cantor maintains Nyxoah stock Overweight with $14 target - Investing.com

Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates - MSN

Trading (NYXH) With Integrated Risk Controls - news.stocktradersdaily.com

Nyxoah Sa’s Earnings Call: Progress Amid Challenges - TipRanks

Nyxoah outlines U.S. Genio launch plan with 50-member team as FDA approval expected Q2 2025 - MSN

Nyxoah S.A. (NASDAQ:NYXH) Q1 2025 Earnings Call Transcript - Insider Monkey

Nyxoah Reports Q1 2025 Financial Results and FDA Progress - TipRanks

Nyxoah Q1 2025 Earnings Call Transcript - MarketBeat

Nyxoah Nears FDA Approval for Genio® System Amid Q1 2025 Results - TipRanks

Nyxoah (NYXH) Nears FDA Approval for Genio System in the U.S. | - GuruFocus

Nyxoah reports Q1 EPS (EUR 0.60) vs. (EUR 0.42) last year - TipRanks

Nyxoah Reports First Quarter Financial and Operating Results - The Manila Times

Nyxoah Nears FDA Approval for Sleep Apnea Device as Q1 Revenue Hits €1.1M | NYXH Stock News - Stock Titan

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. – NYXH - Bluefield Daily Telegraph

Earnings To Watch: Nyxoah SA (NYXH) Reports Q1 2025 Result - GuruFocus

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - PR Newswire

Nyxoah (NYXH) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Publication relating to transparency notifications - Stock Titan

Nyxoah SA Schedules Shareholders’ Meetings for June 2025 - TipRanks

Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025 - Yahoo Finance

Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 - The Manila Times

REG-Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 - TradingView

Renaissance Technologies LLC Purchases Shares of 23,400 Nyxoah S.A. (NASDAQ:NYXH) - Defense World

Long Term Trading Analysis for (NYXH) - news.stocktradersdaily.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A.NYXH - Bluefield Daily Telegraph

Nyxoah S.A. (NASDAQ:NYXH) Shares Bought by Geode Capital Management LLC - Defense World

LPL Financial LLC Buys Shares of 12,700 Nyxoah S.A. (NASDAQ:NYXH) - Defense World

Press Release Distribution & PR Platform - ACCESS Newswire

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Stifel cuts Nyxoah stock price target to $14, maintains Buy rating - Investing.com Canada

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NYXH